The U.S. market for AI-enabled ophthalmic diagnostic devices is projected to grow from $72.5 million in 2026 to $267.2 million by 2033, expanding at a 20.5% CAGR. Growth is driven by rising diabetes-related eye diseases, FDA clearances for autonomous screening devices, and increasing adoption in primary care and underserved areas. Innovations like portable retinal cameras and AI apps enhance early detection and screening efficiency, supported by insurance coverage and clinical guidelines. This trend is expected to improve access to eye care and strengthen preventive vision health management through 2033.
The U.S. AI-enabled ophthalmic diagnostic devices market is projected to grow significantly by 2033, offering a $267.2 million opportunity. For readers following the health sector, here is Pluang's market snapshot as of Nov 13, 2026 22:52 WIB: out of 150 priced US health stocks, 56 rose and 94 fell. Notable movers include WGS (GeneDx Holdings Corp) at USD 49.70 with a -4.18% change and balanced order activity, OSCR (Oscar Health Inc) at USD 30.66 down 4.01% with 100% sell orders, and CGC (Canopy Growth Corp) at USD 0.55 down 3.80% with mostly sell orders.
Solo, a company specializing in privacy-preserving human verification, has integrated its SDK into JellyJelly, a social video app co-founded by Venmo's co-founder. This integration ensures that every JellyJelly account belongs to a real, unique perso...
The global medical display monitors market, valued at $2.8 billion in 2025, is projected to grow to $4.0 billion by 2033 with a CAGR of 4.6%. Growth is fueled by rising adoption of digital imaging systems, demand for accurate diagnostics, and healthc...
On November 12, 2026, Nokia executive Pallavi Mahajan acquired 89 shares of Nokia Corporation at a price of €7.63 per share. This insider purchase is officially reported under EU Market Abuse Regulation Article 19. Such transactions by company execut...
Victoria Hanrahan, a senior executive at Nokia Corporation, purchased 6 shares of Nokia stock at a price of €7.63 per share on November 12, 2026. This transaction was reported under EU Market Abuse Regulation Article 19, indicating transparency in in...
David Heard, a senior manager at Nokia Corporation, purchased 1,139 shares of the company on November 12, 2026, at a price of €7.63 per share. This transaction was reported under EU Market Abuse Regulation, signaling insider confidence or strategic i...
